VTAK

Flyte's Vision Jet Fleet to Be Featured on Blade Platform, Expanding Distribution across One of the Industry's Leading Air Mobility Networks Strategic Partnership Expected to Increase Aircraft Utilization, Customer Acquisition, Brand Awareness, and Platform-Driven Revenue Opportunities Strategic Relationship Further Validates Flyte's Regional Air Mobility Model and Expands Reach into Blade's Ecosystem FORT MILL, S.C., July 21, 2026 (GLOBE NEWSWIRE) -- Fly Flyte, Inc. ("FLYTE"), the Regional Air Mobility subsidiary of Catheter Precision, Inc. (NYSE:VTAK), today announced a strategic partnership with Blade Urban Air Mobility ("Blade") designed to expand customer reach, increase booking op

8-K - Catheter Precision, Inc. (0001716621) (Filer)

EFFECT - Catheter Precision, Inc. (0001716621) (Filer)

424B3 - Catheter Precision, Inc. (0001716621) (Filer)

Every FLYTE aircraft combines the Cirrus Vision Jet’s CAPS whole-aircraft parachute and Safe Return Emergency Autoland with onboard LifeVac life-saving equipment. Partnership reflects FLYTE’s safety-first philosophy, integrating advanced aviation technology with onboard medical emergency preparedness. "Safety isn’t one feature. It’s a system." From aircraft selection and pilot training to emergency automation and onboard medical equipment, safety is built into every layer of the FLYTE experience. FORT MILL, S.C., July 07, 2026 (GLOBE NEWSWIRE) -- Fly Flyte, Inc. ("Flyte"), the rapidly growing Regional Air Mobility subsidiary of Catheter Precision, Inc. (NYSE:VTAK), today announced a st

FORT MILL, S.C., July 02, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE:VTAK) ("VTAK" or the "Company"), today announced continued operational growth following the launch of its enhanced digital booking platform, www.flyflyte.com. During the first six months of 2026, Flyte acquired more than 1,000 new platform users, facilitated 118 flights across its growing network, and generated more than $1.0 million in revenue as demand continued to increase across multiple distribution channels. The Flyte platform allows customers to instantly price and book a Flyte Jet through a seamless digital experience, bringing a level of transparency and accessibility that ha

First Quarter Results Filed: Creatd filed its Quarterly Report for the period ended March 31, 2026, reviewed by the Company's PCAOB-registered independent auditors, highlighting significant balance sheet developments following the disposition of Flyte.SEC Registration Progress: The Company has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission as part of its initiative to re-establish SEC reporting status.Annual Meeting Update: Creatd has revised the record date for its annual shareholder meeting to Friday, June 26, 2026, and the meeting date to Monday, August 3, 2026. Shareholders of record as of June 26, 2026, will be entitled to vote at the meeting

Partnership positions Flyte within elite professional sports ecosystem through leading talent agency GSE Worldwide Collaboration highlights growing demand for efficient regional travel solutions among professional athletes FORT MILL, S.C., June 22, 2026 (GLOBE NEWSWIRE) -- Flyte, the rapidly growing Regional Air Mobility subsidiary of Catheter Precision, Inc. (NYSE:VTAK), today announced a partnership with sports and entertainment agency GSE Worldwide and PGA TOUR professional Emiliano Grillo that began this past weekend in the U.S. Open Championship. Grillo delivered an impressive performance at the 2026 U.S. Open, climbing as high as third place on the leaderboard during the champions

S-1 - Catheter Precision, Inc. (0001716621) (Filer)

Strategic investors support Volato’s AI-driven aviation strategy and next phase of growth across software-enabled operating platforms Volato Group, Inc. (NYSE:SOAR) ("Volato" or the "Company") today announced the closing of a $2.2 million private investment in public equity ("PIPE") financing priced at $0.34 per share. The financing strengthens Volato’s balance sheet and provides additional capital flexibility as the Company advances its AI-focused strategy, including the application of its artificial intelligence technology, aviation operating experience, and software development capabilities to private aviation and other software-enabled markets. Volato is also evaluating acquisition,

Flyte Gains Access to Fast-Growing Private Aviation Membership Network While Unlocking New Revenue Opportunities across Its Cirrus Vision Jet Fleet Creates Additional Distribution Channel for Flyte and Enhances Empty Leg Inventory Available to Vaunt Members FORT MILL, S.C., June 11, 2026 (GLOBE NEWSWIRE) -- Fly Flyte, Inc. ("Flyte"), the rapidly growing Regional Air Mobility subsidiary of Catheter Precision, Inc. (NYSE:VTAK), today announced that it has joined the Vaunt operator network, a membership-based private aviation platform owned by Volato Group, Inc. (NYSE:SOAR). Vaunt connects private aviation travelers with available flights through a growing network of operators and recently

ATLANTA, June 08, 2026 (GLOBE NEWSWIRE) -- Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE:VTAK), focused on making private aviation more accessible and flexible for modern travelers, today announced that it has made a strategic investment in Volato Group, Inc. (NYSE:SOAR). As part of the transaction, VTAK acquired approximately 2.9 million shares of SOAR and will own approximately 7.5% of the company's outstanding common stock. This investment provides a basis to explore potential future collaboration to improve access, efficiency, and innovation across private aviation. "This strategic investment represents an exciting opportunity for both organizations,"

8-K - Catheter Precision, Inc. (0001716621) (Filer)

Investment strengthens balance sheet as Company evaluates non-binding AI infrastructure and technology transaction opportunities Volato Group, Inc. (NYSE:SOAR) (the "Company" or "Volato"), a technology company focused on building scalable software and data solutions that improve the reliability and intelligence of high-stakes business decisions, today announced the signing of a definitive agreement to obtain a $2.2 million strategic investment lead by Catheter Precision, Inc. (NYSE:VTAK), and other institutional investors with experience investing in artificial intelligence and emerging technology companies. The investment of restricted common stock will strengthen Volato's balance shee

8-K - Catheter Precision, Inc. (0001716621) (Filer)

10-Q - Catheter Precision, Inc. (0001716621) (Filer)

NT 10-Q - Catheter Precision, Inc. (0001716621) (Filer)

Company Deploys Scalable Short-Haul Model Following Kentucky Derby to Monetize Peak Travel Window Flagship Routes from NYC, Boston, DC, and Philadelphia Positioned to Drive Immediate Revenue, High Utilization, and Dense Flight Activity NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE:VTAK) ("VTAK" or the "Company"), today announced the positioning of aircraft across the Northeast to support increased travel demand this coming weekend in anticipation of the Preakness Stakes on Saturday, May 16th. The program centers on Baltimore/Washington International Airport (BWI), the primary access point for race attendees, wit

FORT MILL, SC, May 04, 2026 (GLOBE NEWSWIRE) -- — Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE:VTAK) ("VTAK" or the "Company"), today announced increased flight capacity and the launch of a targeted hiring initiative following the shutdown of Spirit Airlines, which ceased operations on May 2, 2026 after failing to secure funding. Spirit Airlines' abrupt exit has led to widespread flight cancellations, impacted approximately 17,000 employees of which over 2,400 were pilots, and stranded passengers nationwide, marking one of the largest U.S. airline disruptions in recent decades. The disruption has reduced available capacity across key domestic routes, cont

10-K/A - Catheter Precision, Inc. (0001716621) (Filer)

Positioned to Meet Accelerating Travel Activity across New York City, The Hamptons, Nantucket and Martha's Vineyard Scalable Short-Haul Luxury Aviation Platform Targeting Key Regional Travel Markets FORT MILL, S.C., April 28, 2026 (GLOBE NEWSWIRE) -- Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE:VTAK) ("VTAK" or the "Company"), today announced the expansion of its Cirrus Vision Jet fleet ahead of peak summer demand, scaling short-haul service from New York City to East Hampton, Nantucket, Martha's Vineyard, Newport, and Cape Cod. The expansion targets one of the most concentrated luxury travel corridors in the United States, a set of routes where trips th

8-K - Catheter Precision, Inc. (0001716621) (Filer)

FORT MILL, S.C., April 21, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE:VTAK) today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for key claims covering its proprietary surgical vessel closing pressure device, marking a significant milestone in the Company's intellectual property strategy. Following a rigorous examination process, the USPTO confirmed the novelty and patentability of VTAK's technology over existing prior art. The allowed claims provide protection across both the core device architecture and its method of use, creating a comprehensive and defensible intellectual property position around a foundational compo

Major Carriers Accelerate Route Cuts as Economics Break Down, Creating Multi-Billion-Dollar Opportunity in Regional Air Mobility Flyte Expands Focus on High-Frequency Short-Haul Routes to Capture Surging Demand as Industry Economics Continue to Shift FORT MILL, S.C., April 20, 2026 (GLOBE NEWSWIRE) -- Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE:VTAK), today announced it is accelerating expansion in short-haul markets as major global airlines rapidly retreat from regional routes amid rising fuel costs, operational constraints, and shifting route economics. This pullback reflects a structural shift, creating a sustained opportunity for high-frequency regio

Transaction Delivers Fully Consolidated, Revenue-Generating, Aviation Business with Accelerating Growth Positions VTAK for Scalable Expansion in Regional Air Mobility Ahead of eVTOL Commercialization FORT MILL, S.C., April 16, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE:VTAK) today announced it received shareholder approval on April 15th of the definitive agreement to acquire Fly Flyte, Inc. ("Flyte") executed on March 9. The March 9th transaction establishes Flyte as a wholly owned operating subsidiary, delivering immediate consolidation of revenue, assets, and operating performance into VTAK. Full Ownership, Consolidated Revenue and Immediate Operating Exposure Flyte ope